Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Reinisch

Showing results (191-200 of 352) with videos related to

Pageof 36
Sort By:
Radiology|February 28, 2023
Evaluation of Intestinal Fibrosis with <sup>68</sup>Ga-FAPI PET/MR Enterography in Crohn DiseaseMartina Scharitzer, Andrea Macher-Beer, Thomas Mang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2025
Efficacy of Etrasimod in Ulcerative Colitis: Analysis of ELEVATE UC 52 and ELEVATE UC 12 by Baseline Endoscopic SeverityAndres J Yarur, Walter Reinisch, Shannon Chang, et al.
American Journal of Human Genetics|August 16, 2006
A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colonKlaus Fellermann, Daniel E Stange, Elke Schaeffeler, et al.
The American Journal of Gastroenterology|August 2, 2008
A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's diseaseWalter Reinisch, Julian Panés, Marc Lémann, et al.
Gastroenterology|May 2, 2002
The value of serologic markers in indeterminate colitis: a prospective follow-up studySofie Joossens, Walter Reinisch, Séverine Vermeire, et al.
Crohn'S & Colitis 360|March 1, 2024
Association Between Smoking Status and the Efficacy and Safety of Tofacitinib in Patients with Ulcerative ColitisDavid T Rubin, Joana Torres, Miguel Regueiro, et al.
Gastroenterology|September 1, 2014
Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitisOmoniyi J Adedokun, William J Sandborn, Brian G Feagan, et al.
Clinical and Translational Gastroenterology|April 29, 2016
Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT-SC Maintenance Study Extension Through 1 YearPeter R Gibson, Brian G Feagan, William J Sandborn, et al.
Hepatology (Baltimore, Md.)|October 24, 2002
Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID miceMarkus F Wolschek, Christiane Thallinger, Malgorzata Kursa, et al.
Gastroenterology|June 23, 2019
Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel DiseasesParambir S Dulai, Laurent Peyrin-Biroulet, Silvio Danese, et al.
Pageof 36

Showing results (191-200 of 352) with videos related to

Sort By:
Pageof 36
Radiology|February 28, 2023
Evaluation of Intestinal Fibrosis with <sup>68</sup>Ga-FAPI PET/MR Enterography in Crohn DiseaseMartina Scharitzer, Andrea Macher-Beer, Thomas Mang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2025
Efficacy of Etrasimod in Ulcerative Colitis: Analysis of ELEVATE UC 52 and ELEVATE UC 12 by Baseline Endoscopic SeverityAndres J Yarur, Walter Reinisch, Shannon Chang, et al.
American Journal of Human Genetics|August 16, 2006
A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colonKlaus Fellermann, Daniel E Stange, Elke Schaeffeler, et al.
The American Journal of Gastroenterology|August 2, 2008
A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's diseaseWalter Reinisch, Julian Panés, Marc Lémann, et al.
Gastroenterology|May 2, 2002
The value of serologic markers in indeterminate colitis: a prospective follow-up studySofie Joossens, Walter Reinisch, Séverine Vermeire, et al.
Crohn'S & Colitis 360|March 1, 2024
Association Between Smoking Status and the Efficacy and Safety of Tofacitinib in Patients with Ulcerative ColitisDavid T Rubin, Joana Torres, Miguel Regueiro, et al.
Gastroenterology|September 1, 2014
Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitisOmoniyi J Adedokun, William J Sandborn, Brian G Feagan, et al.
Clinical and Translational Gastroenterology|April 29, 2016
Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT-SC Maintenance Study Extension Through 1 YearPeter R Gibson, Brian G Feagan, William J Sandborn, et al.
Hepatology (Baltimore, Md.)|October 24, 2002
Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID miceMarkus F Wolschek, Christiane Thallinger, Malgorzata Kursa, et al.
Gastroenterology|June 23, 2019
Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel DiseasesParambir S Dulai, Laurent Peyrin-Biroulet, Silvio Danese, et al.
Pageof 36